undefined
EUTM file information

018192540


February 4, 2020

Trademark Summary

The trademark application was filed by Olink Proteomics AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on February 12, 2020, and it was registered by office on May 21, 2020 without any oppositions.

It was designated 'Basic Application' for International Application 1563334 at the World Intellectual Property Organization (WIPO).

The application was filed in Swedish (English was selected as the second language).

Change of name and professional address of the trademark registration was recorded on July 14, 2022. Change of name and address of the trademark registration was recorded on March 11, 2024.


Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Chemicals used in scientific analysis, research and for industrial use
    2. Chemicals for detection of molecules including molecular proteins and peptides
    3. Chemical kits including sample dilution, antibodies, enzymes, detection solutions, polymerase
    4. Incubation stabilizers and control chemicals for research use and use in drug development.
  • The mark was filed in class 5 with Chemicals for diagnostic use for medical or veterinary purposes.
  • The mark was filed in class 9 with following description of goods:
    1. Apparatus and instruments for scientific and diagnostic use
    2. Apparatus and instruments used in the detection of molecules, molecular proteins and peptides
    3. Diagnostic apparatus, instruments and software used in scientific analysis and detection of molecules for non-medical purposes
    4. Kits for research use and drug development namely primer plates, containers and ampoules with incubation solutions, probe liquids, dilution and detection solutions as well as control liquids.
  • The mark was filed in class 42 with following description of goods:
    1. Research regarding detection of molecules, molecular proteins and peptides
    2. Drug development
    3. Diagnostic development
    4. Data science (biostatistics) services
    5. Laboratory biomarker analysis services and related data analysis.